Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.94% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Financials | 0.79% |
| 5 | Healthcare | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11376
PUT
Arq
ARQ
$94.8M
| $169K | ﹤0.01% |
31,500
+6,000
| +24% | +$26.3K |
|
11377
Zentalis Pharmaceuticals
ZNTL
$371M
| $169K | ﹤0.01% |
145,769
+40,082
| +38% | +$52.9K |
|
|
MHI
11378
DELISTED
Pioneer Municipal High Income Fund
MHI
| $169K | ﹤0.01% |
18,433
-864
| -4% | -$7.84K |
|
11379
Cytosorbents Corp
CTSO
$21.8M
| $169K | ﹤0.01% |
+131,853
| New | +$132K |
|
11380
PUT
inTEST
INTT
$149M
| $168K | ﹤0.01% |
23,100
-3,100
| -12% | -$19.7K |
|
11381
PUT
Eton Pharmaceutcials
ETON
$1.78B
| $168K | ﹤0.01% |
11,800
-7,900
| -40% | -$125K |
|
|
IMSR
11382
Terrestrial Energy
IMSR
$579M
| $168K | ﹤0.01% |
15,146
-25,145
| -62% | -$280K |
|
11383
PLAYSTUDIOS Inc
MYPS
$60M
| $168K | ﹤0.01% |
128,316
-1,148
| -0.9% | -$1.58K |
|
|
AOMR
11384
Angel Oak Mortgage REIT
AOMR
$196M
| $168K | ﹤0.01% |
17,832
-636
| -3% | -$5.78K |
|
11385
PUT
Vestis
VSTS
$1.7B
| $168K | ﹤0.01% |
29,300
+12,900
| +79% | +$90.5K |
|
|
CMCM
11386
Cheetah Mobile
CMCM
$91.9M
| $168K | ﹤0.01% |
35,843
-5,532
| -13% | -$22.3K |
|
|
QIDX
11387
Indexperts Quality Earnings Focused ETF
QIDX
$40M
| $168K | ﹤0.01% |
+15,860
| New | +$160K |
|
11388
Takeda Pharmaceutical
TAK
$57.7B
| $167K | ﹤0.01% |
10,810
-36,219
| -77% | -$535K |
|
11389
Ascent Industries
ACNT
$142M
| $167K | ﹤0.01% |
13,244
-35,521
| -73% | -$452K |
|
|
PNNT
11390
PUT
Pennant Park Investment Corp
PNNT
$245M
| $167K | ﹤0.01% |
+24,400
| New | +$161K |
|
|
MTA
11391
PUT
Metalla Royalty & Streaming
MTA
$1.03B
| $167K | ﹤0.01% |
43,400
+28,800
| +197% | +$91.8K |
|
11392
IZEA Worldwide
IZEA
$54.2M
| $167K | ﹤0.01% |
66,121
-2,288
| -3% | -$5.43K |
|
11393
Anika Therapeutics
ANIK
$281M
| $166K | ﹤0.01% |
15,735
-3,675
| -19% | -$46.4K |
|
11394
BlackRock MuniYield Quality Fund
MQY
$800M
| $166K | ﹤0.01% |
14,963
+3,279
| +28% | +$36.3K |
|
11395
Forrester Research
FORR
$233M
| $166K | ﹤0.01% |
16,788
+92
| +0.6% | +$915 |
|
11396
PUT
Sally Beauty Holdings
SBH
$1.51B
| $166K | ﹤0.01% |
17,900
-19,500
| -52% | -$168K |
|
11397
CALL
Teucrium Wheat Fund
WEAT
$341M
| $166K | ﹤0.01% |
7,460
+3,980
| +114% | +$91.5K |
|
11398
PUT
Alphatec Holdings
ATEC
$1.48B
| $165K | ﹤0.01% |
14,900
-4,100
| -22% | -$47.1K |
|
|
AVR
11399
Anteris Technologies
AVR
$880M
| $165K | ﹤0.01% |
43,618
+10,483
| +32% | +$42.6K |
|
11400
Arcos Dorados Holdings
ARCO
$1.68B
| $165K | ﹤0.01% |
20,942
+10,370
| +98% | +$78.4K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.